SRT-100™ is an Optimal Therapy Modality for Non-Melanoma Skin Cancers


Featuring our SharpBeam precision superficial radiotherapy, the SRT-100™ is an excellent treatment option for patients with non-Melanoma (NMSC) skin cancers, such as Basal Cell Carcinoma (BCC) and Squamous Cell Carcinoma (SCC). Ask your doctor about SRT-100™ when you weigh your treatment options!

The Benefits of SRT

Along with eliminating the risks for post-surgical infections and complications, the SRT-100™ provides patients and physicians with a safe and effective treatment option that offers many benefits, including:

  1. 95%+ cure rates that rival surgery
  2. No anesthesia, cutting, bleeding, stitching or pain
  3. No downtime or lifestyle restrictions
  4. Super cosmesis, no unsightly scarring
  5. No need for post-treatment reconstructive surgeries